WPHM OTC
Winston Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -66.7%
1Y: -66.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+208.2% ▲
Gross Profit
$1M
+212.1% ▲
Operating Income
-$3M
+47.6% ▲
Net Income
-$3M
+48.4% ▲
EPS (Diluted)
$-0.04
+60.0% ▲
EBITDA
-$3M
+47.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2005 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $453K | $1M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +208.2% |
| Cost of Revenue | $20K | $209K | $0 | $9K | $9K |
| Gross Profit | -$20K | -$209K | $0 | $444K | $1M |
| Gross Margin | — | — | — | 98.1% | 99.4% |
| R&D Expenses | $0 | $0 | $0 | $3M | $2M |
| SG&A Expenses | $188K | $210K | $215K | $2M | $2M |
| Operating Expenses | $198K | $217K | $215K | $6M | $4M |
| Operating Income | -$218K | -$426K | -$215K | -$5M | -$3M |
| Operating Margin | — | — | — | -1156.6% | -196.6% |
| Interest Expense | $0 | $39K | $0 | $0 | $0 |
| Income Before Tax | $0 | $0 | $0 | -$5M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$231K | -$465K | -$180K | -$5M | -$3M |
| Net Margin | — | — | — | -1136.2% | -190.4% |
| EPS (Diluted) | $-0.40 | $-0.80 | $-0.08 | $-0.10 | $-0.04 |
| EBITDA | -$208K | -$418K | -$200K | -$5M | -$3M |
| Shares Outstanding | 629647 | 606970 | 2M | 53M | 61M |